Serum-free polypeptide composition for promoting proliferation of mesenchymal stem cells
A technology of polypeptide composition and stem cells, applied in the field of cell proliferation, can solve the problems of inability to meet the requirements of mass production, high price, high risk of introduction of animal-derived proteins, etc. Effects of chemical properties and immunophenotypic stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0063] The preparation of the polypeptide composition described in the present application can be prepared according to the methods well known to those skilled in the art. After the specific time is mixed, the components are filtered and sterilized in the filter membrane, and then added to the α-MEM basal medium and mixed evenly, that is, Serum-free medium for promoting proliferation of mesenchymal stem cells (UC-MSCs) was obtained.
[0064] The mesenchymal stem cell-promoting polypeptide composition provided by the present invention has clear chemical composition, no animal source, no serum, can realize the rapid proliferation of UC-MSCs, solve the problem of insufficient number of cells, and maintain the biological characteristics and immunity of mesenchymal stem cells Phenotypic stability.
Embodiment 1
[0067] Example 1 Preparation of serum-free medium
[0068] 1) Based on α-MEM basal medium, prepare serum-free medium according to the following raw material ratio:
[0069] Non-essential amino acids: 1% by volume;
[0070] Glutamine: 1~4 mM;
[0071] Lipid mixture: 1vol%;
[0072] ITS: 1vol%;
[0073] Recombinant human serum albumin: 2.5g / L;
[0074] Recombinant human epidermal growth factor: 20µg / L;
[0075] Recombinant human fibronectin: 10µg / L;
[0076] L-glutathione: 2mg / L;
[0077] β-mercaptoethanol: 2mg / L;
[0078] Tripeptide-1: 10µg / L;
[0079] Tripeptide-2: 10µg / L;
[0080] Hexapeptide-9: 10µg / L;
[0081] Palmitoyl Hexapeptide-12: 10µg / L;
[0082] Laminin-derived peptide: 50µg / L;
[0083] α-MEM basal medium 10.2g / L;
[0084] The above-mentioned components were dissolved in water at room temperature and fully dissolved to obtain the polypeptide composition of the present application as the experimental group 2; and then sterilized by filtration through a 0....
Embodiment 2
[0144] Example 2 Morphological observation and activity detection of UC-MSCs
[0145] Select the P3 generation UC-MSCs to carry out the experiment, and the UC-MSCs are divided into 1×10 4 / cm 2 The density was inoculated in T25 culture flasks, with 3 replicates in each group; placed in 5% CO 2 Culture in an incubator at 37°C; collect images of UC-MSCs after 48 hours of culture, and the results are as follows: figure 1 as shown, figure 1 Middle panel A is the morphological diagram of UC-MSCs in control group 1, panel B is the morphological diagram of UC-MSCs in control group 2, panel C is the morphological diagram of UC-MSCs in experimental group 1, and panel D is the morphological diagram of UC-MSCs in experimental group 2 Morphological diagram, Figure E is the morphological diagram of UC-MSCs of experimental group 3.
[0146] Depend on figure 1 It can be seen that the UC-MSCs in each group grew in a single layer of adherent, and most of the cells were long spindle-shaped...
PUM
Property | Measurement | Unit |
---|---|---|
Epidermal growth factor | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com